Glutathione‐Induced In Situ Michael Addition between Nanoparticles for Pyroptosis and Immunotherapy

Most tumor treatments will fail when ignoring competition and cooperation between each cancer cell and its microenvironment. Inspired by game theory, therapeutic agents can be introduced to compete for intracellular molecules to disrupt the cooperation between molecules and cells. Biomineralized oxi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Angewandte Chemie International Edition 2023-05, Vol.62 (20), p.e202301866-n/a
Hauptverfasser: Zhen, Wenyao, Liu, Yang, An, Shangjie, Jiang, Xiue
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Most tumor treatments will fail when ignoring competition and cooperation between each cancer cell and its microenvironment. Inspired by game theory, therapeutic agents can be introduced to compete for intracellular molecules to disrupt the cooperation between molecules and cells. Biomineralized oxidized (−)‐epigallocatechin‐3‐o‐gallate (EGCG)–molybdenum ion coordination nanoparticles were prepared for disrupting redox equilibria and simultaneously reacting with intracellular GSH in a Michael addition to form large aggregates that can mechanically disrupt endosomal and plasma membranes, stimulating pyroptosis and anti‐tumor immunological responses for versatile inhibition of different types of tumors. This design disrupts the cooperation between molecules and between cancer and immune cells, achieving an optimal payoff in competition and cooperation in cancer therapy. Epigallocatechin‐3‐o‐gallate (EGCG)–molybdenum ion coordination nanoparticles were prepared by biomineralization. In cancer cells, they disrupt the redox equilibrium and simultaneously compete for and consume intracellular glutathione (GSH) to form large aggregates, which mechanically disrupt the endosomal and plasma membranes, thus inducing pyroptosis and releasing inflammatory factors for activating immunological responses.
ISSN:1433-7851
1521-3773
DOI:10.1002/anie.202301866